Drawing for FLUIDINOVA THE NANO-HYDROXYAPATITE SPECIALIST

USPTO serial 79381129

FLUIDINOVA THE NANO-HYDROXYAPATITE SPECIALIST

Reviewed by CopyMark Law Group

Reg. 7616886Status 700Registered
Filing date
Status date
Registration date
Dec 24, 2024
Examiner
O'BRIEN, JENNIFER LYNN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with FLUIDINOVA THE NANO-HYDROXYAPATITE SPECIALIST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elizabeth Lee D'Amore

Elizabeth Lee D'Amore Lucas & Mercanti, LLP100 S. Jefferson Road, Suite 202Whippany, NJ 07981United States

Goods and services

ClassDescriptionStatusFirst use
001Chemicals being chemicals additives for use in the manufacture of cosmetics, chemical preparations being chemical preparations for use in the manufacture of cosmetics, synthetic materials being synthetic calcium phosphates; all of the foregoing consisting of in whole or significant part of nano-hydroxyapatiteACTIVE—
005Pharmaceutical and veterinary preparations for the treatment and prevention of bone diseases and conditions, namely for bone regeneration, bone strength promotion, bone repair, bone grafting, bone reconstruction, bone loss reduction, collagen promotion for anti-aging, teeth filling material, namely, material for stopping teeth, dental wax; all of the foregoing consisting of in whole or significant part of nano-hydroxyapatite; dietetic substances, namely, dietetic foods adapted for veterinary purposes in the form of granules, chewing gums, tablets, food supplements adapted for medical use; food for babies; plasters, namely, materials for medical dressings; disinfectants; preparations for destroying vermin; fungicides, herbicidesACTIVE—
010Surgical, medical, dental and veterinary apparatus and instruments, namely, artificial limbs, eyes and teeth; orthopedic articles, namely, implantable scaffolds comprising artificial materials for maintaining tissue contour in the nature of bone scaffolds, injectable bone substitutes for surgical use, namely, bioactive ceramic biomaterials, namely, inorganic calcium phosphate for implants for use as bone substitutes, inorganic calcium phosphate for bone scaffolds; all of the foregoing consisting of in whole or significant part of nano-hydroxyapatiteACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 9, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 9, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 9, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 9, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 24, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 24, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 5, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 5, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 16, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 25, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 20, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Sep 20, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 20, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 20, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 21, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 21, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 21, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 23, 2024RFNTREFUSAL PROCESSED BY IB—
Jun 6, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 6, 2024RFRRREFUSAL PROCESSED BY MPU—
Jun 4, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 16, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 2024DOCKASSIGNED TO EXAMINER—
Oct 24, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 20, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 19, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance